FDA Argues To 5th Circuit That Its Ivermectin Warnings Were Within Its Purview
NEW ORLEANS — Responding to the contention of a group of physicians made to the Fifth Circuit U.S. Court of Appeals that a Texas federal court erred in ruling that the...To view the full article, register now.
Already a subscriber? Click here to view full article